EGFR and adenocarcinoma: More interestingly, we found that patients with pulmonary nodules carrying the DD genotype had an increased risk of adenocarcinoma and a lower probability of EGFR gene mutation (OR = 0.312, 95% CI, 0.101–0.968, p = 0.044).